Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 37

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 37
---
 (except in the case of his own compensation, which is determined by the Compensation and Talent Management Committee and the Board of Directors). In addition, with respect to promotions and new hires, the Compensation and Talent Management Committee considers the predecessor’s base salary. The Company views base salary as a fixed component of executive compensation that compensates the executive officer for the daily responsibilities assumed in keeping the Company operating throughout the year. The Compensation and Talent Management Committee reviews executive officers’ salaries annually at the end of the fiscal year and establishes the base salaries for the upcoming fiscal year. The base salaries paid to our named executive officers during 2025 are set forth in the “Salary” column of the Summary Compensation table later in this Proxy Statement. In May 2025, the Compensation and Talent Management Committee approved adjustments to base salaries for fiscal 2026, as set forth below:

| Name         | FY2025 Salary |            | FY2026 Salary |            | % Increase EffectiveApril 1, 2025* |
|:-------------|:--------------|-----------:|:--------------|-----------:|:-----------------------------------|
| Mr. Lombardi |               | $1,000,000 |               | $1,000,000 | 0%                                 |
| Ms. Sacco    |               |   $700,000 |               |   $715,000 | 2.1%                               |
| Mr. Mekhail  |               |   $528,000 |               |   $544,000 | 3%                                 |
| Mr. P’Pool   |               |   $546,000 |               |   $562,000 | 3%                                 |
| Mr. Zerillo  |               |   $370,000 |               |   $381,000 | 3%                                 |

* Increases approved in May were retroactive to beginning of fiscal year.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 49 |

Executive Compensation

Annual Cash Incentive Plan The Annual Incentive Plan (“AIP”) provides our executive officers with the ability to earn additional cash compensation based on a percentage of base salary and the Company’s performance. The Company views the AIP as a performance-based component of executive compensation that motivates and incentivizes the executive officers to achieve the short-term goals of the Company and our stockholders. For 2025, the Compensation and Talent Management Committee chose the following as the corporate financial goals for the AIP:

| Metric              |